ClinicalTrials.govpublic full text
A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment
aplastic anemia, bone marrow failure, low blood cell counts, platelet count increase, blood cell production, thrombopoietin receptor agonist, avatrombopag, treatment-resistant disease (refractory disease), relapsed disease, immunosuppressive therapy, rare blood disorder, blood transfusion reduction
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 839130
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.